ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
IntraLinks Holdings
13.01
+0.0000
成交量:
- -
成交额:
- -
市值:
7.55亿
市盈率:
-37.17
高:
13.01
开:
13.01
低:
13.01
收:
13.01
数据加载中...
总览
公司
新闻
公告
我们为什么投资Pendle?
Bixin Ventures
·
2023-04-17
三生国健(688336.SH)重组抗IL-4Rα人源化单克隆抗体注射液获得药物临床试验批准通知书
智通财经
·
2023-04-14
流动性池:你需要知道的一切
老雅痞
·
2022-11-01
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IL/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IL\",,,,,undefined,":{"symbol":"IL","market":"US","secType":"STK","nameCN":"IntraLinks Holdings","latestPrice":13.01,"timestamp":1575925200000,"preClose":13.01,"halted":4,"volume":0,"delay":0,"floatShares":40200000,"shares":58020000,"eps":-0.35,"marketStatus":"退市","change":0,"latestTime":"12-09 16:00:00 EST","open":13.01,"high":13.01,"low":13.01,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.35,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1281067200000,"exchange":"NYSE","adjPreClose":13.01,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IL\",,,,,undefined,":{"symbol":"IL","floatShares":40200000,"roa":"--","roe":"--","lyrEps":0,"shares":58020000,"dividePrice":0,"high":13.01,"amplitude":0,"preClose":13.01,"low":13.01,"week52Low":6.22,"pbRate":"2.85","week52High":13.72,"institutionHeld":0,"latestPrice":13.01,"eps":-0.35,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.35,"open":13.01},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IL\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2328074423","title":"我们为什么投资Pendle?","url":"https://stock-news.laohu8.com/highlight/detail?id=2328074423","media":"Bixin Ventures","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2328074423?lang=zh_cn&edition=fundamental","pubTime":"2023-04-17 12:32","pubTimestamp":1681705975,"startTime":"0","endTime":"0","summary":"随著去中心化金融(DeFi)的不断成熟,这类收益的机会也将逐步增加。","market":"us","thumbnail":"data:image/png;base64,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","type":0,"news_type":0,"thumbnails":["data:image/png;base64,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"],"rights":{"source":"jinse_stock","url":"https://www.jinse.com/blockchain/3416844.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.jinse.com/blockchain/3416844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_stock","symbols":["IL","PT","BK4166"],"gpt_icon":0},{"id":"2327423112","title":"三生国健(688336.SH)重组抗IL-4Rα人源化单克隆抗体注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2327423112","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2327423112?lang=zh_cn&edition=fundamental","pubTime":"2023-04-14 15:42","pubTimestamp":1681458128,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三生国健 公告,公司重组抗IL-4Rα人源化单克隆抗体注射液收到国家药品监督管理局核准签发的慢性鼻窦炎伴鼻息肉临床试验《药物临床试验批准通知书》,目前SSGJ-611在中国中重度特应性皮炎受试者中开展的一项II期临床研究已完成全部患者入组,并将于近期开展慢性鼻窦炎伴鼻息肉适应症的II期临床试验。据悉,SSGJ-611产品是公司创新研发,拥有自主知识产权的人源化抗IL-4Rα单克隆抗体,具有全新的氨基酸序列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/910582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688336","IL","BK0239","BK1576","03347","BK1583","BK1141"],"gpt_icon":0},{"id":"2280369396","title":"流动性池:你需要知道的一切","url":"https://stock-news.laohu8.com/highlight/detail?id=2280369396","media":"老雅痞","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2280369396?lang=zh_cn&edition=fundamental","pubTime":"2022-11-01 13:38","pubTimestamp":1667281134,"startTime":"0","endTime":"0","summary":"流动性池中需要多少代币流动性?在建立流动性池时,你需要考虑哪些因素?流动性池到底是如何运作的?","market":"hk","thumbnail":"data:image/png;base64,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","type":0,"news_type":0,"thumbnails":["data:image/png;base64,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"],"rights":{"source":"jinse_stock","url":"https://www.jinse.com/blockchain/2563599.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.jinse.com/blockchain/2563599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_stock","symbols":["IL"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-02","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":0.03,"name":null,"time":"盘后","type":"earning","dateTimestamp":1478059200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-05-03","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":0.01,"name":null,"time":"盘后","type":"earning","dateTimestamp":1462248000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-02-24","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":0,"name":null,"time":"盘后","type":"earning","dateTimestamp":1456290000000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2015-11-04","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":-0.02,"name":null,"time":"盘后","type":"earning","dateTimestamp":1446613200000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2015-08-05","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":-0.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1438747200000,"reportTimeType":"post","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IL\",market:\"US\",delay:false,,,undefined,":{}}}